BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15623817)

  • 21. Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.
    Montero-Conde C; Martín-Campos JM; Lerma E; Gimenez G; Martínez-Guitarte JL; Combalía N; Montaner D; Matías-Guiu X; Dopazo J; de Leiva A; Robledo M; Mauricio D
    Oncogene; 2008 Mar; 27(11):1554-61. PubMed ID: 17873908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis.
    Galland F; Lacroix L; Saulnier P; Dessen P; Meduri G; Bernier M; Gaillard S; Guibourdenche J; Fournier T; Evain-Brion D; Bidart JM; Chanson P
    Endocr Relat Cancer; 2010 Jun; 17(2):361-71. PubMed ID: 20228124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of borderline thyroid tumors by gene expression array analysis.
    Arora N; Scognamiglio T; Lubitz CC; Moo TA; Kato MA; Zhu B; Zarnegar R; Chen YT; Fahey TJ
    Cancer; 2009 Dec; 115(23):5421-31. PubMed ID: 19658182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial activity in XTC.UC1 cells derived from thyroid oncocytoma.
    Savagner F; Chevrollier A; Loiseau D; Morgan C; Reynier P; Clark O; Stepien G; Malthiery Y
    Thyroid; 2001 Apr; 11(4):327-33. PubMed ID: 11349830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
    Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
    J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis.
    Giordano TJ; Kuick R; Thomas DG; Misek DE; Vinco M; Sanders D; Zhu Z; Ciampi R; Roh M; Shedden K; Gauger P; Doherty G; Thompson NW; Hanash S; Koenig RJ; Nikiforov YE
    Oncogene; 2005 Oct; 24(44):6646-56. PubMed ID: 16007166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression in thyroid autonomous adenomas provides insight into their physiopathology.
    Wattel S; Mircescu H; Venet D; Burniat A; Franc B; Frank S; Andry G; Van Sande J; Rocmans P; Dumont JE; Detours V; Maenhaut C
    Oncogene; 2005 Oct; 24(46):6902-16. PubMed ID: 16027733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.
    Weber F; Teresi RE; Broelsch CE; Frilling A; Eng C
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3584-91. PubMed ID: 16822819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genes differentially expressed in thyroid carcinoma identified by comparison of SAGE expression profiles.
    Pauws E; Veenboer GJ; Smit JW; de Vijlder JJ; Morreau H; Ris-Stalpers C
    FASEB J; 2004 Mar; 18(3):560-1. PubMed ID: 14715705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic and transcriptomic characterization of the mitochondrial-rich oncocytic phenotype on a thyroid carcinoma background.
    Cavadas B; Pereira JB; Correia M; Fernandes V; Eloy C; Sobrinho-Simões M; Soares P; Samuels DC; Máximo V; Pereira L
    Mitochondrion; 2019 May; 46():123-133. PubMed ID: 29631022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. microRNA expression in autonomous thyroid adenomas: Correlation with mRNA regulation.
    Floor SL; Trésallet C; Hébrant A; Desbuleux A; Libert F; Hoang C; Capello M; Andry G; van Staveren WC; Maenhaut C
    Mol Cell Endocrinol; 2015 Aug; 411():1-10. PubMed ID: 25916957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
    Bryson PC; Shores CG; Hart C; Thorne L; Patel MR; Richey L; Farag A; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):581-6. PubMed ID: 18559722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aggressive inherited and sporadic medullary thyroid carcinomas display similar oncogenic pathways.
    Ameur N; Lacroix L; Roucan S; Roux V; Broutin S; Talbot M; Dupuy C; Caillou B; Schlumberger M; Bidart JM
    Endocr Relat Cancer; 2009 Dec; 16(4):1261-72. PubMed ID: 19675075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors.
    Puskas LG; Juhasz F; Zarva A; Hackler L; Farid NR
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):177-86. PubMed ID: 16171553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression profiles in thyroid carcinomas.
    Takano T; Hasegawa Y; Matsuzuka F; Miyauchi A; Yoshida H; Higashiyama T; Kuma K; Amino N
    Br J Cancer; 2000 Dec; 83(11):1495-502. PubMed ID: 11076659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Markers of cell proliferation, apoptosis, and angiogenesis in thyroid adenomas: a comparative immunohistochemical and genetic investigation of functioning and nonfunctioning nodules.
    Viacava P; Bocci G; Tonacchera M; Fanelli G; DeServi M; Agretti P; Berti E; Goletti O; Aretini P; Resta ML; Bevilacqua G; Naccarato AG
    Thyroid; 2007 Mar; 17(3):191-7. PubMed ID: 17381350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential gene expression in pituitary adenomas by oligonucleotide array analysis.
    Morris DG; Musat M; Czirják S; Hanzély Z; Lillington DM; Korbonits M; Grossman AB
    Eur J Endocrinol; 2005 Jul; 153(1):143-51. PubMed ID: 15994756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular signatures of thyroid follicular neoplasia.
    Borup R; Rossing M; Henao R; Yamamoto Y; Krogdahl A; Godballe C; Winther O; Kiss K; Christensen L; Høgdall E; Bennedbaek F; Nielsen FC
    Endocr Relat Cancer; 2010 Sep; 17(3):691-708. PubMed ID: 20668010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
    Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
    Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid gene expression in familial nonautoimmune hyperthyroidism shows common characteristics with hyperfunctioning autonomous adenomas.
    Hébrant A; Van Sande J; Roger PP; Patey M; Klein M; Bournaud C; Savagner F; Leclère J; Dumont JE; van Staveren WC; Maenhaut C
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2602-9. PubMed ID: 19383781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.